This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
Clinical trial NCT07327632 · RECRUITING
Trial details
- NCT number
- NCT07327632
- Sponsor
- Innovent Biologics Technology Limited (Shanghai R&D Center)
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2026-12-31
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.